European Parliament And Council Of EU "Not Far Apart" On Scrutiny Of High-Risk Devices, IVDs
This article was originally published in SRA
Executive Summary
The provision relating to the scrutiny of high-risk products under the proposed EU regulations on medical devices and IVDs has at last made it onto the agenda of the joint talks between the European Parliament, Council of the European Union and the European Commission which were held on December 3.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.